Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Procter & Gamble Health LtdIndustry : Pharmaceuticals - Multinational
BSE Code:500126NSE Symbol: PGHLP/E(TTM):39.73
ISIN Demat:INE199A01012Div & Yield %:4.79EPS(TTM):136.52
Book Value(Rs):324.2526631Market Cap ( Cr.):9004.5Face Value(Rs):10
    Change Company 
( In Cr)
 Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Dec 2018
INCOME :      
Sales Turnover 1151.261229.621114.411008.731355.86848.99
Excise Duty0.000.000.000.000.000.00
Net Sales1151.261229.621114.411008.731355.86848.99
Other Income 15.6318.3913.1918.1068.89767.93
Stock Adjustments -0.87-2.854.75-1.7313.033.47
Total Income1166.021245.161132.351025.101437.781620.39
EXPENDITURE :      
Raw Materials 329.69358.99344.55310.39444.47272.83
Power & Fuel Cost8.5012.8814.7012.9719.0912.23
Employee Cost 215.16206.17167.56153.66182.93131.27
Other Manufacturing Expenses 83.9990.8698.4390.82136.5689.75
Selling and Administration Expenses 181.66196.86203.91173.99257.28192.98
Miscellaneous Expenses 45.5836.3322.3319.1513.155.25
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure864.58902.09851.48760.981053.48704.31
Operating Profit301.44343.07280.87264.12384.30916.08
Interest 0.720.770.420.800.000.00
Gross Profit300.72342.30280.45263.32384.30916.08
Depreciation27.4028.1027.0830.0429.4521.12
Profit Before Tax273.32314.20253.37233.28354.85894.96
Tax80.9489.7960.8163.6094.7850.22
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-8.60-5.060.04-7.125.996.02
Reported Net Profit200.98229.47192.52176.80254.08838.72
Extraordinary Items -14.710.51-0.40-0.31-2.256.11
Adjusted Net Profit215.69228.96192.92177.11256.33832.61
Adjst. below Net Profit 0.67-1.840.700.42-159.42-6.97
P & L Balance brought forward370.91237.07327.70532.261167.97361.12
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 414.9993.79283.85381.78730.3724.90
P & L Balance carried down157.57370.91237.07327.70532.261167.97
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %2600.00950.00525.001300.002300.004400.00
Earnings Per Share-Unit Curr121.07138.23115.98106.51102.04505.25
Earnings Per Share(Adj)-Unit Curr121.07138.23115.98106.51102.04505.25
Book Value-Unit Curr324.24452.34371.38423.92545.99927.78